Clinical trial
Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using…
NCT00272870 · Children's Hospital Medical Center, Cincinnati, Other · Terminated
Key facts
| NCT number | NCT00272870 |
|---|---|
| Title | Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy |
| Official title | A Pilot Study of Temozolomide and 06Benzylguanine for Treatment of Newly Diagnosed High Grade Glioma, Using Autologous Peripheral Blood Stem Cells Genetically Modified for Chemoprotection |
| Lead sponsor | Children's Hospital Medical Center, Cincinnati, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Glioblastoma Multiforme (WHO Grade IV), Anaplastic Astrocytoma (WHO Grade III) |
| Intervention type | Device, Drug, Genetic |
| Interventions | 06Benzylguanine, MGMT P140K, Meltenyi CliniMacs |
| Enrollment | 1 |
| Start date | Dec 1, 2005 |
| Primary completion | Dec 1, 2008 |
| Completion | Aug 1, 2012 |
| First posted | Jan 9, 2006 |
| Last update posted | Aug 29, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: